tradingkey.logo

Electromed Inc

ELMD
查看详细走势图
27.660USD
-0.960-3.35%
收盘 12/22, 16:00美东报价延迟15分钟
231.15M总市值
28.34市盈率 TTM

Electromed Inc

27.660
-0.960-3.35%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.35%

5天

-6.55%

1月

+6.75%

6月

+34.73%

今年开始到现在

-6.40%

1年

-0.25%

查看详细走势图

TradingKey Electromed Inc股票评分

单位: USD 更新时间: 2025-12-22

操作建议

Electromed Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名69/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价36.00。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Electromed Inc评分

相关信息

行业排名
69 / 208
全市场排名
175 / 4578
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
买入
评级
36.000
目标均价
+27.89%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Electromed Inc亮点

亮点风险
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
业绩高增长
公司营业收入稳步增长,连续3年增长33.15%
业绩增长期
公司处于发展阶段,最新年度总收入64.00M美元
利润高增长
公司净利润处于行业前列,最新年度总收入64.00M美元
估值合理
公司最新PE估值28.50,处于3年历史合理位
机构减仓
最新机构持股4.36M股,环比减少0.04%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值216.90K

Electromed Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Electromed Inc简介

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
公司代码ELMD
公司Electromed Inc
CEOCunniff (James L)
网址https://smartvest.com/

常见问题

Electromed Inc(ELMD)的当前股价是多少?

Electromed Inc(ELMD)的当前股价是 27.660。

Electromed Inc的股票代码是什么?

Electromed Inc的股票代码是ELMD。

Electromed Inc股票的52周最高点是多少?

Electromed Inc股票的52周最高点是35.560。

Electromed Inc股票的52周最低点是多少?

Electromed Inc股票的52周最低点是17.730。

Electromed Inc的市值是多少?

Electromed Inc的市值是231.15M。

Electromed Inc的净利润是多少?

Electromed Inc的净利润为7.54M。

现在Electromed Inc(ELMD)的股票是买入、持有还是卖出?

根据分析师评级,Electromed Inc(ELMD)的总体评级为买入,目标价格为36.000。

Electromed Inc(ELMD)股票的每股收益(EPS TTM)是多少

Electromed Inc(ELMD)股票的每股收益(EPS TTM)是0.976。
KeyAI